LSP
Mark Wegter joined LSP in 1998 and is currently Managing Partner. His prime focus and responsibility within LSP is to invest in listed securities and the general management of the firm. Prior to joining LSP, Mark worked as a Senior Analyst at ING Corporate and Investment Banking, covering a wide range of companies and industries to which ING had significant financial exposure. Mark brings over 20 years of hands-on finance and investment experience to the LSP team. As a Director, he plays an active role in determining the successful financing, growth and strategic direction of a suite of innovative life sciences companies across Europe. Among others, Mark currently serves as Chairman of the supervisory board of Kiadis Pharma, a company that is focused on developing new cancer immunotherapeutics. Mark holds a Master’s degree in Business Economics from the Erasmus University of Rotterdam, and lives in Amsterdam with his wife and four children.
This person is not in any teams
This person is not in any offices
LSP
LSP is one of the largest European investment firms providing financing for life sciences and health care companies. LSP’s management has raised over €2 billion ($2.3 billion) and developed more than 120 companies since it started to invest in 1988.